251 related articles for article (PubMed ID: 27153507)
1. Novel brain-penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates.
Chambers JE; Meek EC; Chambers HW
Ann N Y Acad Sci; 2016 Jun; 1374(1):52-8. PubMed ID: 27153507
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of novel phenoxyalkyl pyridinium oximes as brain-penetrating reactivators of cholinesterase inhibited by surrogates of sarin and VX.
Chambers JE; Chambers HW; Funck KE; Meek EC; Pringle RB; Ross MK
Chem Biol Interact; 2016 Nov; 259(Pt B):154-159. PubMed ID: 27387540
[TBL] [Abstract][Full Text] [Related]
3. Testing of novel brain-penetrating oxime reactivators of acetylcholinesterase inhibited by nerve agent surrogates.
Chambers JE; Chambers HW; Meek EC; Pringle RB
Chem Biol Interact; 2013 Mar; 203(1):135-8. PubMed ID: 23123249
[TBL] [Abstract][Full Text] [Related]
4. Novel centrally active oxime reactivators of acetylcholinesterase inhibited by surrogates of sarin and VX.
Chambers JE; Meek EC
Neurobiol Dis; 2020 Jan; 133():104487. PubMed ID: 31158460
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection From Organophosphate-Induced Damage by Novel Phenoxyalkyl Pyridinium Oximes in Rat Brain.
Pringle RB; Meek EC; Chambers HW; Chambers JE
Toxicol Sci; 2018 Dec; 166(2):420-427. PubMed ID: 30496567
[TBL] [Abstract][Full Text] [Related]
6. Novel substituted phenoxyalkyl pyridinium oximes enhance survival and attenuate seizure-like behavior of rats receiving lethal levels of nerve agent surrogates.
Chambers JE; Meek EC; Bennett JP; Bennett WS; Chambers HW; Leach CA; Pringle RB; Wills RW
Toxicology; 2016 Jan; 339():51-57. PubMed ID: 26705700
[TBL] [Abstract][Full Text] [Related]
7. In vivo reactivation by oximes of inhibited blood, brain and peripheral tissue cholinesterase activity following exposure to nerve agents in guinea pigs.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Chem Biol Interact; 2010 Sep; 187(1-3):207-14. PubMed ID: 20223229
[TBL] [Abstract][Full Text] [Related]
8. Reactivation by novel pyridinium oximes of rat serum and skeletal muscle acetylcholinesterase inhibited by organophosphates.
Bennett JP; Meek EC; Chambers JE
J Biochem Mol Toxicol; 2024 Jul; 38(7):e23750. PubMed ID: 38952032
[TBL] [Abstract][Full Text] [Related]
9. Central neuroprotection demonstrated by novel oxime countermeasures to nerve agent surrogates.
Chambers JE; Meek EC
Ann N Y Acad Sci; 2020 Nov; 1479(1):5-12. PubMed ID: 32319115
[TBL] [Abstract][Full Text] [Related]
10. Novel pyridinium oximes enhance 24-h survivability against a lethal dose of nerve agent surrogate in adult female rats.
Garcia JM; Meek EC; Chambers JE
Toxicology; 2020 Dec; 446():152626. PubMed ID: 33159982
[TBL] [Abstract][Full Text] [Related]
11. The oxime pro-2-PAM provides minimal protection against the CNS effects of the nerve agents sarin, cyclosarin, and VX in guinea pigs.
Shih TM; Guarisco JA; Myers TM; Kan RK; McDonough JH
Toxicol Mech Methods; 2011 Jan; 21(1):53-62. PubMed ID: 21117832
[TBL] [Abstract][Full Text] [Related]
12. Nonquaternary reactivators for organophosphate-inhibited cholinesterases.
Kalisiak J; Ralph EC; Cashman JR
J Med Chem; 2012 Jan; 55(1):465-74. PubMed ID: 22206546
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
[TBL] [Abstract][Full Text] [Related]
14. The effect of PON1 enhancers on reducing acetylcholinesterase inhibition following organophosphate anticholinesterase exposure in rats.
Meek EC; Chambers HW; Pringle RB; Chambers JE
Toxicology; 2015 Oct; 336():79-83. PubMed ID: 26275814
[TBL] [Abstract][Full Text] [Related]
15. Amidine-oximes: reactivators for organophosphate exposure.
Kalisiak J; Ralph EC; Zhang J; Cashman JR
J Med Chem; 2011 May; 54(9):3319-30. PubMed ID: 21438612
[TBL] [Abstract][Full Text] [Related]
16. In vitro reactivation of acetylcholinesterase using the oxime K027.
Kuca K; Kassa J
Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases.
Maček Hrvat N; Kalisiak J; Šinko G; Radić Z; Sharpless KB; Taylor P; Kovarik Z
Toxicol Lett; 2020 Mar; 321():83-89. PubMed ID: 31863869
[TBL] [Abstract][Full Text] [Related]
18. Effects of novel brain-penetrating oxime acetylcholinesterase reactivators on sarin surrogate-induced changes in rat brain gene expression.
Dail ME; Brino MLM; Chambers JE
J Biochem Mol Toxicol; 2021 Jun; 35(6):1-10. PubMed ID: 33682265
[TBL] [Abstract][Full Text] [Related]
19. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.
Antonijevic B; Stojiljkovic MP
Clin Med Res; 2007 Mar; 5(1):71-82. PubMed ID: 17456837
[TBL] [Abstract][Full Text] [Related]
20. In vitro reactivation of sarin-inhibited human acetylcholinesterase (AChE) by bis-pyridinium oximes connected by xylene linkers.
Acharya J; Dubey DK; Srivastava AK; Raza SK
Toxicol In Vitro; 2011 Feb; 25(1):251-6. PubMed ID: 20688148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
